Figure 3 | Laboratory Investigation

Figure 3

From: Development of a Real-Time Reverse Transcription Polymerase Chain Reaction Assay for c-myc Expression That Allows the Identification of a Subset of c-myc+ Diffuse Large B-Cell Lymphoma

Figure 3

Survival plots for DLBCL patients, according to c-myc expression. Patients with a high c-myc expression level had significantly shorter overall survival (OS; a) and failure-free survival (FFS; b). International Prognostic Index (IPI) distinguished two categories of patients, in terms of OS (c). High c-myc expression is associated with shorter survival in the low-risk group (d) and in the high-risk group (e), as defined by IPI, although the impact of c-myc is only significant in the latter group of patients.

Back to article page